Differences Between Cirrhosis and Liver Cancer
Jun 01, 2022
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
Cirrhosis and hepatocellular carcinoma (HCC) are two entirely distinct diseases. First, their pathogeneses differ markedly: cirrhosis is a progressive, diffuse, fibrotic condition that can result from multiple etiologies. In contrast, HCC is a malignant, space-occupying lesion of the liver, characterized by high mortality and rapid progression. Although patients may survive with the tumor present, most cases are difficult to control over the long term.
Cirrhosis and hepatocellular carcinoma (HCC) are both relatively common diseases, with a high incidence of hepatic disorders in China. So, what are the key differences between cirrhosis and HCC?
Differences Between Cirrhosis and Hepatocellular Carcinoma
Cirrhosis and HCC are two entirely distinct diseases. First, their pathogenic mechanisms differ significantly: cirrhosis is a progressive, diffuse, fibrotic liver disease that can result from multiple etiologies. In contrast, HCC is a malignant, space-occupying lesion of the liver—characterized by high mortality and rapid progression. Although a small number of patients may survive with tumor presence, most tumors are difficult to control over the long term. Clinically, the symptoms also differ: during the decompensated stage of cirrhosis, predominant manifestations include fatigue, dyspepsia, hepatic insufficiency, and portal hypertension; additionally, multisystem involvement such as endocrine dysfunction and anemia may occur. In intermediate-to-advanced HCC, typical symptoms include progressively worsening right upper quadrant pain, progressive weight loss, fatigue, unexplained low-grade fever, abdominal pain, and diarrhea.
In China, most cases of HCC develop on a background of cirrhosis, making cirrhosis a recognized premalignant condition for HCC. Cirrhosis itself is a benign disorder; if it does not progress to HCC and remains well-controlled—particularly avoiding progression to the decompensated stage—patients may enjoy prolonged survival. However, once HCC develops concurrently with cirrhosis, the condition becomes a malignant disease with potential for distant metastasis. Therefore, early and accurate differentiation between regenerative cirrhotic nodules and malignant HCC masses is critically important.
Maintaining overall health and undergoing regular physical examinations are essential for early detection and timely intervention. We hope this article has been helpful to you.
